Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCyclerion Therap Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$2.66 | -$2.66 | -$2.66 |
| Q2 2026 | 1 | -$3.45 | -$3.45 | -$3.45 |
| Q3 2026 | 1 | -$1.06 | -$0.62 | -$0.85 |
| Q4 2026 | 2 | -$1.13 | -$0.74 | -$0.94 |
| Q1 2027 | 1 | -$0.80 | -$0.80 | -$0.80 |
| Q2 2027 | 1 | -$0.81 | -$0.81 | -$0.81 |
| Q3 2027 | 1 | -$0.78 | -$0.78 | -$0.78 |
| Q4 2027 | 1 | -$0.79 | -$0.79 | -$0.79 |
| Q1 2028 | 1 | -$43.40 | -$43.40 | -$43.40 |
| Q2 2028 | 1 | -$40.60 | -$40.60 | -$40.60 |
| Q3 2028 | 1 | -$42.00 | -$42.00 | -$42.00 |
| Q4 2028 | 1 | -$39.20 | -$39.20 | -$39.20 |
| Q1 2029 | 1 | -$44.80 | -$44.80 | -$44.80 |
| Q2 2029 | 1 | -$51.80 | -$51.80 | -$51.80 |
| Q3 2029 | 1 | -$2.66 | -$2.66 | -$2.66 |
Cyclerion Therap Earnings Date And Information
Cyclerion Therap last posted its earnings results on Tuesday, August 4th, 2026. The company reported $-0.41 earnings per share for the quarter, topping analysts' consensus estimates of $-3.45 by $3.04. The company had revenue of 0 for the quarter and had revenue of 2.07 M for the year. Cyclerion Therap has generated $-8 earnings per share over the last year ($-7.63 diluted earnings per share) and currently has a price-to-earnings ratio of -2.51. Cyclerion Therap has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Cyclerion Therap Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/04/2026 | Q2 2026 | -$3.45 | -$2.87 | 0.58 | $0 | $0 |
| 05/12/2026 | Q1 2026 | N/A | -$5.32 | N/A | $100.00 K | $0 |
| 12/31/2025 | Q4 2025 | N/A | -$1.75 | N/A | N/A | $1.03 M |
| 11/12/2025 | Q3 2025 | -$121.80 | -$2.10 | 119.7 | N/A | $875.00 K |
| 08/05/2025 | Q2 2025 | N/A | -$0.77 | N/A | N/A | $93.00 K |
| 05/06/2025 | Q1 2025 | N/A | -$3.92 | N/A | N/A | $81.00 K |
| 03/04/2025 | Q4 2024 | N/A | $1.47 | N/A | N/A | $1.81 M |
| 11/14/2024 | Q3 2024 | -$6.20 | -$2.03 | 4.17 | $153.00 K | $194.00 K |
| 08/07/2024 | Q2 2024 | N/A | -$3.71 | N/A | N/A | $0 |
| 05/07/2024 | Q1 2024 | -$50.40 | -$4.34 | 46.06 | N/A | $0 |
| 03/05/2024 | Q4 2023 | -$7.40 | -$4.76 | 2.64 | N/A | $0 |
| 11/13/2023 | Q3 2023 | -$6.40 | -$23.52 | -17.12 | N/A | $0 |
| 07/28/2023 | Q2 2023 | -$5.60 | -$12.81 | -7.21 | N/A | $0 |
| 05/11/2023 | Q1 2023 | N/A | -$21.77 | N/A | N/A | $0 |
| 03/22/2023 | Q4 2022 | -$40.60 | -$22.61 | 17.99 | N/A | $0 |
| 11/03/2022 | Q3 2022 | -$7.00 | -$34.79 | -27.79 | N/A | $0 |
| 08/09/2022 | Q2 2022 | -$6.80 | -$45.22 | -38.42 | N/A | $306.00 K |
| 05/04/2022 | Q1 2022 | -$7.20 | -$43.96 | -36.76 | N/A | $711.00 K |
| 02/24/2022 | Q4 2021 | -$6.40 | -$36.61 | -30.21 | N/A | $533.00 K |
| 11/09/2021 | Q3 2021 | -$5.80 | -$36.54 | -30.74 | N/A | $348.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cyclerion Therap Earnings: FAQ's
In the previous quarter, Cyclerion Therap (:KRSA) reported $-0.41 earnings per share (EPS) to beat the analysts' consensus estimate of $-3.45 by $3.04.
The conference call for Cyclerion Therap's latest earnings report can be listened to online.
The conference call transcript for Cyclerion Therap's latest earnings report can be read online.
Cyclerion Therap (:KRSA) has a recorded annual revenue of $2.07 M.
Cyclerion Therap (:KRSA) has a recorded net income of $-3,528,000.Cyclerion Therap has generated $-7.63 earnings per share over the last four quarters.
Cyclerion Therap (:KRSA) has a price-to-earnings ratio of -2.51 and price/earnings-to-growth ratio is 0.03.